Montelukast Prescribing at TODMORDEN GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,712
Total Quantity
41.0K
NHS Cost
£2.1K
vs National Avg
+150%
TODMORDEN GROUP PRACTICE prescribed 1,712 items of Montelukast over the last 12 months at a cost of £2,080 to the NHS. This is 150% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
136
Jun 2026
140
Jun 2026
143
Jun 2026
145
Jun 2026
129
Jun 2026
146
Jun 2026
147
Jun 2026
145
Jun 2026
159
Jun 2026
134
Jun 2026
153
Jun 2026
135
Prescribing Details
| Total Items | 1,712 |
|---|---|
| Total Quantity | 40,980 |
| Total NHS Cost | £2,080 |
| Presentations | 4 different forms |
| vs National Average | +150% |
Montelukast Prescribing Comparison
| This practice | 1,712 items |
|---|---|
| National average per practice | 685 items |
| Difference | +150% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.